ArborGen, the leading supplier of advanced seedling genetics to the global commercial forestry industry, has completed the previously announced sale of its In Vitro business. This sale is representative of the Company’s continued focus on growth and productivity opportunities. North Inlet is pleased to have served as the sole financial advisor to ArborGen on this transaction.